Acciona (ANA)
Madrid Exchange · Spain · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 206.20 |
|---|---|
| 52-week range | 165.00 – 285.00 |
| Return, 1 month / 3 months | −5.7% / −18.4% |
| Return, 1 year / 3 years | +12.2% / +97.5% |
| Trend | Below its 200-day average |
| RSI (14) | 44 |
| Volatility (1 year) | 37.6% |
| Worst drawdown (1 year) | -29.4% |
| Average daily value traded | 20.59M EUR |
| Dividend yield | 2.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Acciona is a Spanish group active in infrastructure and renewable energy. It develops and operates wind and other renewable power plants, and it builds and manages infrastructure such as roads, water treatment and transport systems. Its customers include utilities, public authorities and private clients, and the company is based in Spain, where it also runs construction and engineering work alongside its energy business.
On this site Acciona appears as a stock on the Madrid Exchange (Spain), code ANA, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Acciona (ANA) trades on the Madrid Exchange in Spain. It last closed at EUR 206.20 on 22 October 2026.
Its price-based Market X-Ray is 41 out of 100 (a weak price profile), ranking 160 of 236 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 12.2% and over the last three months it fell 18.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Madrid Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 28 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -7.1% | ||
| From 52-week high | -27.5% | ||
| Momentum | 38 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -18.4% | ||
| 6-month return | -11.7% | ||
| 12-month return, skipping the last month | 19.0% | ||
| Stability (higher is calmer) | 25 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 37.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -29.4% | ||
| Liquidity | 93 · Strong | Trades actively. | |
| Average daily value traded | 20.59M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 47 · Weak | Dividend is small or irregular. | |
| Dividend yield | 2.8% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | −1.2% |
|---|---|
| 1 month | −5.7% |
| 3 months | −18.4% |
| 6 months | −11.7% |
| 1 year | +12.2% |
| 3 years | +97.5% |
| 5 years | +49.4% |
Signals
| 50-day / 200-day average | 209.87 / 221.95 |
|---|---|
| Golden / death cross (60 days) | Death, 21 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 5.89 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 7 Jul 2026 | EUR 5.7487 |
| 8 Jul 2025 | EUR 5.2841 |
| 2 Jul 2024 | EUR 4.8884 |
| 4 Jul 2023 | EUR 4.5099 |
| 5 Jul 2022 | EUR 4.1127 |
| 19 Apr 2022 | EUR 0.2801 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Madrid Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.